Decoding of exosome heterogeneity for cancer theranostics
Clin Transl Med
.
2023 Jun;13(6):e1288.
doi: 10.1002/ctm2.1288.
Authors
Rajib Dhar
1
,
Sukhamoy Gorai
2
,
Arikketh Devi
1
,
Raman Muthusamy
3
,
Athanasios Alexiou
4
5
,
Marios Papadakis
6
Affiliations
1
Department of Genetic Engineering, Cancer and Stem Cell Biology Laboratory, SRM Institute of Science and Technology, Kattankulathur, India.
2
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA.
3
Department of Microbiology, Centre for Infectious Diseases, Saveetha Dental College, Chennai, India.
4
Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, Australia.
5
AFNP Med, Wien, Austria.
6
Department of Surgery II, University Hospital Witten-Herdecke, Heusnerstrasse 40, University of Witten-Herdecke, Wuppertal, Germany.
PMID:
37292029
PMCID:
PMC10251134
DOI:
10.1002/ctm2.1288
No abstract available
Keywords:
biomarkers; cancer; exosome; exosome heterogeneity; therapeutics.
MeSH terms
Exosomes*
Humans
Neoplasms* / diagnosis
Neoplasms* / therapy
Precision Medicine